Sunday, October 24, 2021

Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock deal – ET HealthWorld


New Delhi: Diagnostic chain Metropolis Healthcare on Sunday said it will acquire Dr Ganesan’s Hitech Diagnostic Centre Pvt Ltd in a cash and stock combination deal, to strengthen its leadership position in southern India.

The company’s board has approved the acquisition partly by way of cash consideration of Rs 511 crore and partly by issuance of up to 4,95,000 equity shares of a face value of Rs 2 each on a preferential basis, to the promoter group of Hitech, Metropolis Healthcare said in a regulatory filing.

“The cash consideration will be funded through internal accruals and debt of up to Rs 300 crore,” it added.

S P Ganesan, its promoter and founder, will be part of the leadership team for the next few years to enable a smooth transition and integration with Metropolis, the filing said.

By the acquisition, Metropolis will get an access to 31 laboratories, including three NABL- and ICMR-accredited laboratories and 68 collection centres of Hitech. The acquisition is expected to be completed within three months, it added.

Metropolis Healthcare Managing Director Ameera Shah said, “In line with the strategy to grow, gain market share and increase B2C (business-to-consumer) revenues in focus cities, we are acquiring Hitech Diagnostic Centre which will strengthen our leadership position in the South India market.”

Objective of Metropolis with the acquisition is to increase its market share in focus cities of Chennai and Bengaluru and become leaders in some tier-2 towns in southern India, she added.

“We will capture the mid-segment of the market, increase our B2C revenue contribution and leverage scale benefits through cost synergies,” Shah said.

Dr Ganesan’s Hitech Diagnostic Centre Pvt Ltd Promoter S P Ganesan said Metropolis is the right brand to carry forward the legacy of Hitech. “We shall ensure a smooth integration of Hitech’s business with Metropolis to increase the value for the combined entity through cost synergies and create a much stronger consumer brand in South India.”

The acquisition will allow Metropolis to increase its B2C business in focus cities of Chennai and Bengaluru. It will benefit through optimisation of operational costs in the areas of procurement, supply chain, administration and support resource, laboratory network and back office infrastructure, Metropolis Healthcare said.

It will further allow Metropolis brand to make deeper inroads in different customer segments across key markets in South India, it added.





Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...